logo

195.13

195.13 (-0.32%)

As of Mar 06, 2024

Repligen Corp [RGEN]

Source: 

Company Overview

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs.

CountryUnited States
Headquarterswaltham
Phone Number7814499560
Industry
manufacturing
CEOTony J. Hunt
Websitewww.repligen.com